Potentiation of an antimalarial oxidant drug

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1449-1454

  Winter, R W ^a   Ignatushchenko, Marina ^b   Ogundahunsi, Olumide A T ^c   Cornell, Kenneth A ^b   Oduola, Ayoade M J ^c   Hinrichs, David J ^a   Riscoe, Michael K ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

EXIFONE; RUFIGALLOL; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; DRUG POTENTIATION; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; MALARIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0030878175     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1449     Document Type: Article

References (38)

1. Allahyari, R., A. Strother, I. Fraser, and A. Verbiscar. 1984. Synthesis of certain hydroxy analogues of the antimalarial drug primaquine and their in vitro methemoglobin-producing and glutathione-depleting activity in human erythrocytes. J. Med. Chem. 27:407-410.
2. Atamna, H., M. Krugliak, G. Shalmiev, E. Deharo, G. Pescarmona, and H. Ginsburg. 1996. Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo. Biochem. Pharm. 51:693-700.
3. Atamna, H., G. Pascarmona, and H. Ginsburg. 1994. Hexose-monophosphate shunt activity in intact Plasmodium falciparum-infected erythrocytes and in free parasites. Mol. Biochem. Parasitol. 67:79-89.
4. Bates, M. D., S. R. Meshnick, C. I. Sigler, P. Leland, and M. R. Hollingdale. 1990. In vitro effects of primaquine and primaquine metabolites on exoerythrocytic development in Plasmidium berghei. Am. J. Trop. Med. Hyg. 42:532-537.
5. Bleuler, H., and A. G. Perkin. 1916. An oxidation product of gallic acid. J. Chem. Soc. 109:529-543.
6. Brodie, B. B., J. Axelrod, P. A. Shore, and S. Udenfriend. 1954. Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. J. Biol. Chem. 208:741-749.
7. Desjardins, R., J. Canfield, J. Haynes, and J. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
8. Divo, A., T. Geary, and J. Jensen. 1985. Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture. Antimicrob. Agents Chemother. 27:21-27.
9. Elabbadi, N., M. L. Ancelin, and H. J. Vial. 1992. Use of radioactive ethanolamine incorporation into phospholipids to assess in vitro antimalarial activity by the semiautomated microdilution technique. Antimicrob. Agents Chemother. 36:50-55.
10. Englard, S., and S. Seifter. 1986. The biochemical functions of ascorbic acid. Annu. Rev. Nutr. 6:365-406.
11. Gabay, T., and H. Ginsburg. 1993. Hemoglobin denaturation and iron release in acidified red blood cell lysate - a possible source of iron for intraerythrocytic malaria parasites. Exp. Parasitol. 77:261-272.
12. Ginsburg, H., E. Nissani, and M. Krugliak. 1989. Alkalinization of the food vacuole of malaria parasites by quinoline drugs and alkylamines is not correlated with their antimalarial activity. Biochem. Pharmacol. 38:2645-2654.
13. Golenser, J., E. Marva, and M. Chevion. 1991. The survival of Plasmodium under oxidant stress. Parasitol. Today 7:142-146.
14. Halliwell, B., M. Grootveld, and J. M. C. Gutteridge. 1988. Methods for the measurement of hydoxyl radicals in biochemical systems: deoxyribose degradation and aromatic hydroxylation. Methods Biochem. Anal. 33:59-90.
15. Hewlett, P. 1969. Measurement of the potencies of drug mixtures. Biometrics 25:477-487.
16. Hostettmann, K., and M. Hostettmann (ed.). 1989. Xanthones, vol. 1. Academic Press, London, United Kingdom.
17. Jacob, R., C. Otradovec, R. Russell, H. Munro, S. Hartz, R. McGandy, F. Morrow, and J. Sadowski. 1988. Vitamin C status and nutrient interactions in a healthy elderly population. Am. J. Clin. Nutr. 48:1436-1442.
18. Krogstad, D. J., P. H. Schlesinger, and I. Y. Gluzman. 1985. Antimalarials increase vesicle pH in Plasmodium falciparum. J. Cell Biol. 101:2302-2309.
19. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
20. Maissant, J., C. Bouchoule, P. Canesson, and M. Blanchard. 1983. Hydroxylation des composés aromatiques par le système d'Udenfriend: remplacement de l'acide ascorbique par une réduction électrochimique. J. Mol. Catalysis 18:189-192.
21. Martin, S., A. Oduola, and W. Milhous. 1987. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235:899-901.
22. Marva, E., A. Cohen, P. Saltman, M. Chevion, and J. Golenser. 1989. Deleterious synergistic effects of ascorbale and copper on the development of P. falciparum: in vitro study in normal and in G6PD-deficient erythrocytes. Int. J. Parasitol. 19:779-785.
23. Marva, E., J. Golenser, A. Cohen, N. Kitrossky, R. Har-el, and M. Chevion. 1992. The effects of ascorhate-induced free radicals on Plasmodium falciparum. Trop. Med. Parasitol. 43:17-23.
24. May, J., Z.-C. Qu, and R. Whitesell. 1995. Ascorbic acid recycling enhances the antioxidant reserve of human erythrocytes. Biochemistry 34:12721-12728.
25. Meshnick, S. R., R. E. Taylor, and S. Kamchonwongpaisan. 1996. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60:301-315.
26. Oduola, A. M. J., N. F. Weatherly, J. H. Bowdre, and R. E. Desjardins. 1988. Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. Exp. Parasitol. 66:86-95.
27. Olliaro, P., and D. Goldberg. 1995. The Pasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol. Today 11:294-297.
28. Stocker, R., M. Weidermann, and N. Hunt. 1986. Possible mechanisms responsible for the increased ascorbic acid content of P. vinckei-infected mouse erythrocytes. Biochim. Biophys. Acta 881:391-397.
29. Sultanbawa, M. U. S. 1980. Xanthonoids of tropical plants. Tetrahedron 36:1465-1506.
30. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
31. Udenfriend, S., C. T. Clark, J. Axelrod, and B. B. Brodie. 1954. Ascorbic acid in aromatic hydroxylation. I. A model system for aromatic hydroxylation. J. Biol. Chem. 208:731-739.
32. Vennerstrom, J., W. Ellis, and W. Milhous. 1991. Antimalarial synergism and antagonism, p. 183-222. In D. C. Rideout and T.-C. Chou (ed.), Synergism and antagonism in chemotherapy. Academic Press, Inc., New York, N.Y.
33. Vennerstrom, J. L., and J. W. Eaton. 1988. Oxidants, oxidant drugs and malaria. J. Med. Chem. 31:1269-1277.
34. Vera, J., C. Rivas, F. Velásquez, R. Zhang, I. Concha, and D. Golde. 1995. Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid. J. Biol. Chem. 270:23706-23712.
35. Winter, R. W., K. A. Cornell, L. L. Johnson, and M. K. Riscoe. 1995. Hydroxyanthraquinones as antimalarial agents. Bioorg. Med. Chem. Lett. 5: 1927-1932.
36. Winter, R. W., M. Ignatushchenko, K. A. Cornell, L. L. Johnson, D. J. Hinrichs, and M. K. Riscoe. 1996. Potentiation of the antimalarial agent rufigallol. Antimicrob. Agents Chemother. 40:1408-1411.
37. Winterbourn, C. C. 1979. Comparison of superoxide with other reducing agents in the biological production of hydroxyl radicals. Biochem. J. 182: 625-628.
38. Yayon, A., Z. I. Cabantchik, and H. Ginsburg. 1985. Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc. Natl. Acad. Sci. USA 82:2784-2788.